This implies that any studies that are designed to examine the biological significance of TSG101 and associated molecular mechanisms for a given tumor type (e.g., breast cancer) should be conducted on cell lines and animal models that resemble the main characteristics of a particular cancer-intrinsic subtype (e.g., luminal-type breast cancer models). Here, TSG101 is linked to breast cancer.